Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
FUROSEMIDE · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Furosemide PO - IV | EXPERIMENTAL | Oral furosemide allocated at the beginning of Period 1, then cross-over to IV furosemide (a minimum 7-day diuretic free washout period required between the two periods) |
| Furosemide IV - PO | EXPERIMENTAL | IV furosemide allocated at the beginning of Period 1, then cross-over to oral furosemide (a minimum 7-day diuretic free washout period required between the two periods) |
| Name | Type | Description |
|---|---|---|
| FUROSEMIDE | DRUG | Pharmaceutical form: Solution Route of administration: Intravenous |
| FUROSEMIDE (HOE058) | DRUG | Pharmaceutical form: Tablet Route of administration: Oral |
Inclusion criteria : * Male or female, 18 years old or older, with chronic renal failure undergoing peritoneal dialysis for at least 3 months. * Women of childbearing age should have a negative pregnancy test before administration of the study drug Exclusion criteria: * Contra-indications to furo...